Cargando…

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes

Detalles Bibliográficos
Autores principales:	Cai, Xiaoling, Lin, Chu, Ji, Linong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943829/ https://www.ncbi.nlm.nih.gov/pubmed/35245927 http://dx.doi.org/10.1097/CM9.0000000000002045

Ejemplares similares

Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus
por: Cai, Xiaoling, et al.
Publicado: (2021)

Trends and regional differences in glycemic control of patients with type 2 diabetes in China, 2009–2013
por: Cheng, Jiayu, et al.
Publicado: (2022)

Lipid control in adult Chinese patients with type 2 diabetes: a retrospective analysis of time trends and geographic regional differences
por: Yuan, Yanping, et al.
Publicado: (2022)

The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Hu, Suiyuan, et al.
Publicado: (2021)

Machine learning for the prediction of atherosclerotic cardiovascular disease during 3‐year follow up in Chinese type 2 diabetes mellitus patients
por: Ding, Jinru, et al.
Publicado: (2023)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2021)

The Body Weight Alteration and Incidence of Neoplasm in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Lin, Chu, et al.
Publicado: (2020)

Clinical Characteristics of Young Type 2 Diabetes Patients with Atherosclerosis
por: Yang, Wenjia, et al.
Publicado: (2016)

Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease?
por: Zhao, Yanglu, et al.
Publicado: (2015)

Longitudinal association of egg consumption habits with blood lipids among Chinese adults: results from the Prediction for Atherosclerotic Cardiovascular Disease Risk in China project
por: Zhang, Xinyu, et al.
Publicado: (2022)

Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment
por: Cai, Xiaoling, et al.
Publicado: (2012)

Cardiovascular risk profile and clinical characteristics of diabetic patients: a cross-sectional study in China
por: Lyu, Fang, et al.
Publicado: (2022)

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus
por: Ren, Honghong, et al.
Publicado: (2021)

Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian
por: Cai, Xiaoling, et al.
Publicado: (2013)

Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus
por: Lin, Chu, et al.
Publicado: (2020)

Comparison of Innovative and Traditional Cardiometabolic Indices in Estimating Atherosclerotic Cardiovascular Disease Risk in Adults
por: Huang, Ya-Chin, et al.
Publicado: (2021)

Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
por: Li, Yijun, et al.
Publicado: (2015)

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
por: Rana, Jamal S., et al.
Publicado: (2021)

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
por: Hageman, Steven H J, et al.
Publicado: (2022)

Analysis of the Associations between Vitamin D and Albuminuria or β-Cell Function in Chinese Type 2 Diabetes
por: Cai, Xiaoling, et al.
Publicado: (2014)

Optimization of Medication Regimens in Patients with Type 2 Diabetes and Clinical Atherosclerotic Cardiovascular Disease
por: Prudencio, Jarred, et al.
Publicado: (2021)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis
por: Hu, Suiyuan, et al.
Publicado: (2023)

Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Comment on: Impact of a multidisciplinary intensive education program on type 2 diabetes mellitus patients’ glycemic control and cardiovascular risk factors
por: Al Saeed, Abdulghani H.
Publicado: (2019)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai, Xiaoling, et al.
Publicado: (2020)

Sex Associations Between Air Pollution and Estimated Atherosclerotic Cardiovascular Disease Risk Determination
por: Vallée, Alexandre
Publicado: (2023)

Baseline Triglyceride Level Affected the Efficacy of Vildagliptin in Treating Type 2 Diabetes: A Post Hoc Analysis of the VISION Study
por: Zhou, Lingli, et al.
Publicado: (2019)

Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis
por: Cai, Xiaoling, et al.
Publicado: (2018)

Reflections on a successful hybrid type 1 diabetes summer camp in China during the COVID‐19 pandemic
por: Liu, Wei, et al.
Publicado: (2022)

Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2016)

Inflammatory Biomarkers and Risk of Atherosclerotic Cardiovascular Disease
por: Yu, En, et al.
Publicado: (2018)

Addition of dipeptidyl peptidase‐4 inhibitors to insulin treatment in type 2 diabetes patients: A meta‐analysis
por: Yang, Wenjia, et al.
Publicado: (2017)

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
por: Yang, Xue-Li, et al.
Publicado: (2016)

Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation
por: Foryciarz, Agata, et al.
Publicado: (2022)

Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System
por: Vassy, Jason L., et al.
Publicado: (2020)

Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
por: Khera, Rohan, et al.
Publicado: (2020)

Effect of DASH Diet Versus Healthy Dietary Advice on the Estimated Atherosclerotic Cardiovascular Disease Risk
por: Said, Marwa S., et al.
Publicado: (2021)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Comment on: Fracture risk assessment in patients with type 2 diabetes mellitus
por: Jawad, Ali S.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v09aq0kgu6oc1d8gksvultvvvb